AstraZeneca Pharma India Q2 Results and Key Leadership Appointments
AstraZeneca Pharma India Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 11:26 pm
AstraZeneca Pharma India Q2 Results and Key Leadership Appointments AstraZeneca Pharma India reported Q2'26 revenue from operations of Rs 7,291.0 mn, up 30.4% YoY from Rs 5,590.9 mn, with profit after tax rising 15.0% YoY to Rs 623.3 mn. Profit before tax stood at Rs 884.9 mn after Rs 149.6 mn in exceptional items. For H1'26, revenue reached Rs 14,118.9 mn while PAT stood at Rs 1,002.6 mn. The board appointed Atul Tandon as CFO effective 9th Nov'26 and Krishnamurthy Narayanan Iyer as Independent Director for five years from 5th Nov'26.
Original exchange filing (PDF)
More announcements from AstraZeneca Pharma India Ltd
- Please find the enclosed document of the Company as per the captioned subject. This is being resubmitted as the weblink was not correctly re-directing to the relevant web page in the earlier .... 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 07 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about General Updates 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 05 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about Appointment/ Change in designation of Senior Management Personnel 路 05 Nov 2026
